Association between benzodiazepine outpatient treatment and risk of early seizure recurrence in emergency patients with seizure: A multicenter retrospective study

Author(s):  
Melanie Roussel ◽  
Anthony Chauvin ◽  
Pierrick Le Borgne ◽  
Marie Drogrey ◽  
Xavier Eyer ◽  
...  
2008 ◽  
Vol 15 (5) ◽  
pp. 261-267 ◽  
Author(s):  
Christophe Choquet ◽  
Jaqueline Depret-Vassal ◽  
Benoit Doumenc ◽  
Sophie Sarnel ◽  
Enrique Casalino

2020 ◽  
Vol 35 (8) ◽  
pp. 583-588
Author(s):  
Hao Zhang ◽  
Ming Pei Xu ◽  
Zuo Qing Dong ◽  
Shao Hua Liu ◽  
Ai Jun Yang

Objective To evaluate whether the risk of infections is increased with the use of air from outpatient rooms to prepare bleomycin foam. Methods Settling plates were adopted to collect bacteria from outpatient room air, operating theatre air, human serum albumin, bleomycin solution and bleomycin foam prepared with both outpatient room and operating theatre air. The plates were placed in an incubator at 37°C for 48 h, and the number of bacterial colonies was recorded using colony-forming units. The results were analysed by the t-test. A retrospective study was then performed to evaluate the outpatient safety of bleomycin foam. Results The number of colony-forming units in the bleomycin foam produced using both operating and outpatient room air was very low, with no statistic difference. No infection cases were reported in clinical evaluation. Conclusion Using the air from outpatient treatment rooms for bleomycin foam preparation does not increase the risk of infections.


2021 ◽  
Vol 39 (15_suppl) ◽  
pp. e18762-e18762
Author(s):  
Tommy Jean ◽  
Julie Lemieux ◽  
Geneviève Soucy ◽  
Francis Caron ◽  
Dominique Leblanc

e18762 Background: Febrile neutropenia is a serious complication of chemotherapy leading to hospitalization in cancer patients. According to a practice guidelines published by ASCO (American Society of clinical Oncology) and IDSA (Infectious Diseases Society of American) in 2018, patients meeting the criteria for low-risk neutropenia according to the MASCC score (Multinational Association for Supportive Care in Cancer Score) could be treated as outpatient and thus avoid hospitalization. The objective of the study was to assess the number and proportion of patients who were hospitalized for febrile neutropenia in university hospital that would have met the low risk criteria of febrile neutropenia. We also wanted to know if these patients had experienced a favorable outcome during hospitalization. Methods: We performed a retrospective study including all patients admitted for febrile neutropenia in 3 hospitals in Quebec City during the period from January 1, 2018 to December 31, 2019. We excluded patients with leukemia, as well as stem cell transplant patients. The chart review retrospectively established the MASCC score for each patient. We also established according to predefined criteria whether the clinical course was favorable or unfavorable. Results: A total of 177 hospitalizations met our inclusion criteria. We found that 101/177 (57.1%) of hospitalized patients met the criteria for low-risk neutropenia according to the MASCC score (score of 21 and above). Of this number 74/177 (41.8%) presented all the criteria suggested for receiving outpatient treatment. In these patients 70/177 (39.5%) presented a favorable evolution during hospitalization and thus 4/177 (2.3%) presented an unfavorable evolution. Among these, 2 patients presented with infections considered major (2 bacteremia), 1 patient developed acute renal failure, and 1 other patient developed delirium. There was no death or admission to the intensive care unit in these 4 patients. Conclusions: According to this retrospective study, about 40% of patients admitted for febrile neutropenia filled the criteria of low risk febrile neutropenia and could be treated as outpatient. Given this represents a significant proportion of patients, a protocol for systematic follow-up of outpatient treatment with low-risk febrile neutropenia should be put in place.


2015 ◽  
Vol 8 (1) ◽  
pp. 10-15 ◽  
Author(s):  
Sung-Suk Lee ◽  
Su-Gwan Kim ◽  
Ji-Su Oh ◽  
Seong-Yong Moon ◽  
Jae-Seek You ◽  
...  

2016 ◽  
Vol 50 (4) ◽  
pp. 194-196
Author(s):  
Gaurav Khandelwal ◽  
Sunit Pathak

ABSTRACT Aim To establish fusidic acid ointment in the treatment of recurrent epistaxis in children as a local antiseptic. Materials and methods It was a retrospective study and a total of 184 pediatric patients’ data were analyzed. Ninety-seven patients were found to be fitting in selection criteria. The time of presentation, number of episodes, treatment received, and follow-ups were noted. Results were confirmed over the phone. Results Ninety-five patients had simple bleed and were managed on outpatient treatment with fusidic acid ointment and saline nasal drops, while two required admission and underwent electrocautery of offending vessel. Out of the 95 patients, 10 had initial failure of treatment in the 1st month, but with continued treatment were subsequently treated. Fifteen of these 95 had episodes in the next season. The incidence of bleeding was more in summers than winters in children. Conclusion Fusidic acid ointments are safe and effective in the treatment of recurrent epistaxis in children. Clinical significance: The effectivity of fusidic acid in epistaxis has never been studied. This study can establish it as an antiseptic ointment in the treatment of recurrent epistaxis. How to cite this article Khandelwal G, Pathak S, Sharma M. Fusidic Acid Ointment in Treatment of Recurrent Epistaxis in Children. J Postgrad Med Edu Res 2016;50(4):194-196.


2019 ◽  
Vol 63 (3) ◽  
pp. 351-357 ◽  
Author(s):  
Hidayet Yücesoy ◽  
İlker Geçmen ◽  
Tuba Adıgüzel ◽  
Mine Karagülle ◽  
Müfit Zeki Karagülle

Sign in / Sign up

Export Citation Format

Share Document